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N-methyl-D-aspartate receptors (NMDARs), a major subtype of glutamate receptor mediating excitatory transmission throughout the CNS, participate in ischemia-induced neuronal
death. Unfortunately, undesired side effects have limited the strategy of inhibiting/blocking
NMDARs as therapy. Targeting endogenous positive allosteric modulators of NMDAR function may offer a strategy with fewer downsides. Here, we explored whether 24S-hydroxycholesterol (24S-HC), an endogenous positive NMDAR modulator characterized recently by
our group, participates in NMDAR-mediated excitotoxicity following oxygen-glucose deprivation (OGD) in primary neuron cultures. 24S-HC is the major brain cholesterol metabolite
produced exclusively in neurons near sites of glutamate transmission. By selectively potentiating NMDAR current, 24S-HC may participate in NMDAR-mediated excitotoxicity following
energy failure, thus impacting recovery after stroke. In support of this hypothesis, our findings indicate that exogenous application of 24S-HC exacerbates NMDAR-dependent excitotoxicity in primary neuron culture following OGD, an ischemic-like challenge. Similarly,
enhancement of endogenous 24S-HC synthesis reduced survival rate. On the other hand,
reducing endogenous 24S-HC synthesis alleviated OGD-induced cell death. We found that
25-HC, another oxysterol that antagonizes 24S-HC potentiation, partially rescued OGDmediated cell death in the presence or absence of exogenous 24S-HC application, and 25HC exhibited NMDAR-dependent/24S-HC-dependent neuroprotection, as well as NMDARindependent neuroprotection in rat tissue but not mouse tissue. Our findings suggest that
both endogenous and exogenous 24S-HC exacerbate OGD-induced damage via NMDAR
activation, while 25-HC exhibits species dependent neuroprotection through both NMDARdependent and independent mechanisms.
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Introduction
Ischemic stroke is a major cause of death and disability in the United States, and excitotoxicity
is a major outcome of the bioenergetic failure associated with stroke [1]. Energy disruption
triggers depolarization, which initiates a positive-feedback cycle of release of glutamate, an
important excitatory (depolarizing) transmitter, and subsequent overactivation of N-methylD-aspartate receptors (NMDARs), a major subtype of glutamate receptors mediating excitatory transmission throughout the CNS. NMDARs participate in ischemia-induced neuronal
injury and death by admitting Ca2+ and promoting excitotoxic cell death [2]. Therefore,
diminishing NMDAR-mediated excitotoxicity may be neuroprotective and benefit stroke outcome. However, undesired side effects have limited the strategy of directly inhibiting/blocking
NMDARs as therapy. Understanding and targeting endogenous positive allosteric modulators
of NMDAR function may produce fewer downsides since basal (orthosteric) NMDAR function remains unaltered.
We have recently identified a novel class of positive NMDAR modulators– 24S-hydroxychlesterol (24S-HC) and its synthetic analogues [3]. 24S-HC is the major brain cholesterol
metabolite. It is produced by cholesterol 24-hydroxylase (CYP46A1), a neuron-specific
enzyme localized to dendrites [4]. 24S-HC is found abundantly in adult brain tissue (30–
60 μg/g tissue), suggesting that it may regulate normal and pathophysiological NMDAR activity [5, 6]. In addition, 24S-HC has proven to be toxic through mechanisms independent of
NMDARs in neuronal cell lines [7, 8].
Here we assess contributions of 24S-HC to neuronal death associated with oxygen-glucose
deprivation (OGD), especially the role of NMDARs in the actions of 24S-HC. We exploit primary hippocampal neurons, where 24S-HC levels can be readily controlled and measured. We
explored whether manipulating exogenous or endogenous levels of 24S-HC is neuroprotective
against OGD-induced excitotoxicity. We also examined the concentrations of 24S-HC that
exacerbate in vitro injury caused by OGD, and we explored whether exacerbation by 24S-HC
can be entirely ascribed to NMDAR modulation. Moreover, we investigated whether
25-hydroxycholesterol (25-HC), an endogenous oxysterol recently shown to antagonize
24S-HC’s potentiating effects on NMDARs [9], has beneficial effects against OGD-induced
neuronal death. We find that 25-HC neuroprotection is partly dependent on its antagonism of
24S-HC but surprisingly also includes a component that is independent of NMDARs. This
component proved to be species dependent. In sum, targeting an endogenous positive allosteric modulator of NMDARs or perhaps targeting the novel NMDAR independent mechanism
described here may avoid deleterious side effects of NMDAR antagonists as therapeutics [10].

Materials and methods
Cell culture
All animal care and experimental procedures were consistent with National Institutes of
Health guidelines and were approved by the Washington University Animal Studies Committee. Studies involving animals are reported in accordance with the ARRIVE guidelines for
reporting experiments involving animals [11, 12]. Rat or mouse hippocampal cultures were
prepared from postnatal day 1 to 3, pups of both sexes (85% female) anaesthetized with isoflurane. Hippocampal slices (500 μm thickness) were digested with 1 mgmL−1 papain in oxygenated LeibovitzL-15 medium (Life Technologies, Gaithersburg, MD, USA). Tissue was
mechanically triturated in modified Eagle’s medium (MEM; Life Technologies) containing 5%
horse serum, 5% FCS, 17 mM D glucose, 400 μM glutamine, 50 UmL−1 penicillin and
50 μgmL−1 streptomycin. Cells were seeded in modified Eagle’s medium at a density of ~650
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cells per mm2 (onto 25 mm cover glasses coated with 5 mgmL−1 collagen or 0.1 mgmL−1
poly-D-lysine with 1 mgmL−1 laminin). Cultures were incubated at 37˚C in a humidified
chamber with 5%CO2/95% air. Cytosine arabinoside (6.7 μM) was added 3–4 days after plating
to inhibit glial proliferation. The following day, half of the culture medium was replaced with
Neurobasal medium (Life Technologies) plus B27 supplement (Life Technologies).

Oxygen-glucose deprivation and H2O2 toxicity
Mass cultures (13–14 DIV) were exposed to oxygen-glucose deprivation (OGD), in which
original medium containing 25 mM glucose was exchanged for fresh MEM medium with 2.5
mM glucose and exposed to a sealed chamber (Billups-Rothenberg, Del Mar, CA, USA),
humidified and saturated with 95% nitrogen and 5% CO2 at 37˚C, for 2.5 h. The gas exchange
followed the specifications of the chamber manufacturer (flow of 20 Lmin−1 for 4 min to
achieve 100% gas exchange). In some experiments, original medium was exchanged for fresh
MEM medium containing the specified drugs immediately prior to OGD exposure. Controls
were incubated in MEM medium without oxygen deprivation. Following OGD or control
treatment, cells were returned to their original medium and incubated under standard culture
conditions until the cell death assay (24 h later). We used Hoechst 33342 (5 μM) to identify all
nuclei and propidium iodide (PI, 3 μM) for 30 min to stain nuclei of cells with compromised
membranes. Mass cultures (10–14 DIV) challenged with H2O2 were incubated in 100 μM
H2O2 for 60 min in the presence of 20 μM MK-801 during and after the insult to ensure no
NMDAR contribution to toxicity. After a 24 h latent period cell survival was quantified as for
OGD challenge.

Chemicals
SGE-201 was synthesized by previously published methods [3] and was a gift from Sage Therapeutics. D-APV and MK-801 were purchased from Tocris (Bristol, UK). 25-HC was purchased
from Sigma (St. Louis, MO).

Measurement of 24S-HC level in cell culture medium
24-hydroxycholesterol in each medium (100 μL) sample was extracted with 400 μL of methanol. Deuterated 24-hydroxycholesterol-d7 (10 ng) was added to each medium sample before
extraction. Extracted 24-hydroxycholesterol and the internal standard were derivatized with
N,N-dimethylglycinate (DMG) to increase sensitivity. Oxysterol analysis was performed with
a Shimadzu 20AD HPLC system, a LeapPAL autosampler coupled to a triple quadrupole mass
spectrometer (API 4000) operated in MRM mode. The positive ion ESI mode was used for
detection of derivatized oxysterols. The study samples were injected in duplicate for data averaging. Data processing was conducted with Analyst 1.5.1 (Applied Biosystems). Quantification
of 24S-hydroxycholesterol was determined by the deuterium labeled internal standard spiked
in each sample. 24-hydroxycholesterol data were normalized as ng/mL for various media.

Data analysis
Five 10X microscope fields were quantified per condition per experiment, yielding >100 total
neurons for each condition. Ratios of healthy neurons were quantified as the fraction of PInegative neuronal nuclei to total neuronal nuclei. Automated cell counting algorithms (ImageJ
software, National Institutes of Health, Bethesda, MD, USA) were used for cell counts. Toxicity
experiments were treated as a dependent sample design [13] in which sibling cultures plated in
identical media and exposed to OGD at the same time were compared by repeated measures
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statistics. Results are shown as means ± SEM. Comparative statistics were performed with Student’s t-test or one-way repeated measures ANOVA where indicated.

Results
24S-HC exacerbates OGD damage, which is APV sensitive
Cell death induced by hypoxia and OGD in hippocampal cultures is NMDAR dependent [14–
17]. Because 24S-HC and its analogues increase NMDAR activity [3], these compounds may
exacerbate OGD-induced cell death by potentiating NMDAR activity. Effects of 24S-HC on
NMDAR function saturate at ~10 μM [3]. Consistent with these observations, exogenous
application of 24S-HC at 2 μM to WT rat hippocampal cultures 14 days in vitro enhanced
OGD-induced cell death (Fig 1A and 1B). This cell death was rescued by co-treatment with an
NMDAR antagonist, APV, prior to and during OGD, confirming that the exacerbation of cell
death was NMDAR dependent [14–17].
We also tested whether elevation of 24S-HC by genetically overexpressing CYP46A1 to
mimic mature 24S-HC levels could augment endogenous 24S-HC and OGD-induced toxicity.
WT rat primary hippocampal cultures were infected with an AAV-CYP46A1-GFP virus. Conditioned culture medium from cells infected with AAV-CYP46A1-GFP exhibited significant
elevation of 24S-HC level compared to control AAV-GFP infected cultures (Fig 1C), verifying
virus effectiveness. Overexpression of CYP46A1 increased cell death following OGD relative to
controls (Fig 1D and 1E). Again, APV prevented OGD-induced cell death in both AAV-CYP46A1-GFP and AAV-GFP-infected neuron cultures (Fig 1E), implicating NMDARs in the
increased damage. Taken together, these results suggest that 24S-HC exacerbates OGDinduced damage, and its actions exclusively involve NMDAR activation. Furthermore, because
OGD occurs in unconditioned culture medium devoid of 24S-HC (see Methods and below),
the results suggest that locally elevated levels of 24S-HC may drive NMDAR activity to exacerbate damage.

Endogenous 24S-HC exacerbates OGD-induced damage
We next investigated whether down-regulation of endogenous 24S-HC protects against OGDinduced cell death. In CYP46A1 knockout (KO) mice, 24S-HC is greatly reduced, and deficits
of NMDAR-dependent functions including basal EPSCs, synaptic plasticity, learning and
memory have been reported [4, 18], suggesting reduced NMDAR activity in these mice. When
comparing OGD-induced cell death in WT and KO hippocampal cultures, we observed a significantly higher survival rate in KO cultures, suggesting that reduction of endogenous
24S-HC protects against OGD-induced damage (Fig 2). This result is consistent with our previous findings in hippocampal slices, where KO slices exhibit resistance to OGD-induced synaptic depression [19].
Because basal levels of 24S-HC are expected to be low in unconditioned medium used for
OGD, we were surprised at the difference in OGD neuronal survival between KO and WT cultures. We hypothesized that despite low basal concentrations, toxic insults may increase extracellular 24S-HC concentration in medium during insult to levels that modulate NMDAR
dependent damage. To test whether OGD increases 24S-HC concentration to levels necessary
to exacerbate OGD neuronal injury, we sampled culture medium immediately after the 2.5 h
OGD insult. We found that 24S-HC concentration in OGD-challenged cultures was not
different than control dishes (Fig 2B and 2C). Moreover, absolute, bulk levels of 24S-HC in
the low-glucose medium of both OGD and control cultures were very low compared with
24S-HC levels in the original conditioned medium (Fig 2B), as a result of the short conditioning period of the fresh, low-glucose medium. Following insult, cells were returned to the
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Fig 1. 24S-HC exacerbates OGD-induced, NMDAR-dependent cell death. (A) Representative images
showing propidium iodide (PI)–labeled, compromised cells in control, OGD, OGD+24S-HC (2 μM), and OGD
+24S-HC+APV (50 μM). Scale bar is 30 μm. (B) Survival rate was calculated as number of dead cells
normalized to total cells and compared between control, OGD, OGD+APV, OGD+24S-HC, and OGD
+24S-HC+APV. Cells treated with OGD and 24S-HC exhibited significantly lower survival rate compared to
those treated with OGD alone (n = 7 cultures for each group; one-way repeated measures ANOVA with
Bonferroni’s post hoc test, *P < 0.05). (C) 24S-HC levels in the culture media were measured from control (no
virus infection), AAV8-GFP, and AAV8-CYP46A1-GFP infected cell cultures (n = 4 cultures for each group;
one-way repeated measures ANOVA and Bonferroni post hoc test, *P < 0.05). (D) Representative images
showing PI-labeled dead cells in GFP-expressing cells and CYP46A1 GFP-expressing cells with or without
OGD challenges. Scale bar is 30 μm. (E) Survival rate was compared between control GFP and CYP46A1
GFP-expressing cells with/without OGD, and with OGD+ APV. Following OGD treatment, CYP46A1 GFPexpressing cells had significantly lower survival rate compared to GFP-expressing cells (n = 5 cultures for
each group; two-way repeated measures ANOVA with paired t test, *P <0.05).
https://doi.org/10.1371/journal.pone.0174416.g001

original conditioned medium containing full glucose concentration. Levels of 24S-HC in this
medium were measured 1 hr later and were not significantly elevated by the preceding OGD
insult (Fig 2B and 2C). Basal levels of 24S-HC in conditioned medium from mouse cultures
were 14.1 ± 2.8 ng/ml, or approximately 35 nM (Fig 2B). This concentration is likely justthreshold for eliciting NMDAR potentiation [3] but is unlikely to contribute directly to OGD
injury in our conditions because conditioned medium containing 24S-HC is removed in favor
of low-glucose unconditioned medium for OGD experiments (Fig 2A). Comparator 24S-HC
concentrations in conditioned medium from one KO culture were 0.5 ng/ml (~1.2 nM) in
baseline medium and 0.5 ng/ml (~1.3 nM) in OGD conditioned medium. Thus, the low levels
in KO culture conditioned medium verify that WT 24S-HC results from ongoing enzymatic
synthesis. Overall, these results suggest that bulk 24S-HC levels are unlikely to contribute to
OGD damage in mouse cultures under our conditions, and local levels of 24S-HC near sites of
release may mediate effects. Our results do not support the idea that 24S-HC levels are elevated
by insult.
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Fig 2. Endogenous 24S-HC exacerbates OGD-induced, NMDAR-dependent cell death. (A) Survival rate
was compared between WT and KO cells with/without OGD challenges, and with OGD/APV co-treatment.
Following OGD treatment, KO cells had significantly higher survival rate compared to WT cells (n = 5 cultures
for WT and 5 cultures for KO; one-way ANOVA with Bonferroni’s post hoc test, *P < 0.05). (B) 24S-HC
concentration (ng/ml) was measured in MEM and the original conditioned medium (CM) immediately following
OGD insult and one hour after, respectively. (C) 24S-HC levels measured both immediately following OGD
insult and one hour after insult, as shown in (B), were normalized to 24S-HC measured in the sibling untreated
control cultures shown in (B) (n = 5 for control cultures and 6 for OGD cultures; P > 0.2).
https://doi.org/10.1371/journal.pone.0174416.g002

25-HC is partially neuroprotective against 24S-HC exacerbated damage
and against damage in the absence of 24S-HC
OGD-induced cell death in rat cultures depended on 24S-HC concentration over a range of 50
nM to 2 μM (Fig 3A). These results suggest that the local level of 24S-HC produced in WT
cells is not saturating. We recently showed that the oxysterol 25-HC non-competitively antagonizes 24S-HC effects on NMDARs [9]. Here we found that co-treatment with 10 μM 25-HC

Fig 3. The 24S-HC exacerbation of OGD damage is concentration dependent and is partially rescued
by 25-HC. (A) Survival was compared between control, OGD, OGD+50 nM 24S-HC, OGD+0.5 μM 24S-HC,
OGD+2 μM 24S-HC, and OGD+2 μM 24S-HC+10 μM 25-HC. Cells treated with OGD and 24S-HC at 0.5 μM
and 2 μM showed significantly poorer survival compared to those treated with OGD alone. Application of
25-HC partially prevented OGD-induced cell death exacerbated by 2 μM 24S-HC. (n = 11 cultures for each
group; one-way repeated measures ANOVA with Bonferroni’s post hoc test, *P < 0.05; **P < 0.01;
***P<0.001). (B) 25-HC not only partially rescued OGD-induced cell death following SGE-201 application,
but also protected against OGD-induced cell death in the absence of 24S-HC analogue application (n = 8
cultures for each group; one-way repeated measures ANOVA with Bonferroni’s post hoc test, *P < 0.05;
**P < 0.01; ***P < 0.001).
https://doi.org/10.1371/journal.pone.0174416.g003
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and 2 μM 24S-HC significantly alleviated OGD-induced cell death relative to that induced by
24S-HC and OGD alone (Fig 3A). Similarly, 1 μ M SGE-201, a synthetic 24S-HC analogue [3],
exacerbated OGD injury, and this enhanced damage was reduced by 10 μM 25-HC (Fig 3B).
Even without exogenous application of 24S-HC, OGD-induced cell death was alleviated by
10 μM 25-HC incubation during the OGD insult (Fig 3B). This result could arise from antagonism of unappreciated local, endogenous 24S-HC activity. However, because measured bulk
endogenous 24S-HC levels are low, it is also possible that, in additional to antagonizing
24S-HC-induced potentiation of NMDARs, 25-HC may have NMDAR-independent neuroprotective effects against OGD damage.

Evidence for NMDAR independent neuroprotective effects of 25-HC
To test whether the entirety of 25-HC’s protective effect involves NMDARs, we applied 25-HC
at different time points relative to the OGD insult, where the contribution of NMDARs is
expected to vary. As a probe of NMDAR involvement at various stages during and after OGD,
we tested APV neuroprotection in a separate group of cultures. As expected, APV was highly
neuroprotective when administered before and during OGD. APV was much less effective
when administered during the latent period following OGD insult, demonstrating a minor contribution of NMDAR activation in this period (Fig 4A). If 25-HC acts through NMDARs, we
would expect a corresponding decrease in effectiveness when 25-HC is administered following
insult. By contrast, cultures treated with 25-HC before or after OGD insult exhibited comparable survival rates (Fig 4B). Thus, despite the minor contribution of NMDARs following OGD,
25-HC neuroprotection was not altered, suggesting the possibility that OGD elicits a degree of
NMDAR independent cell death, against which 25-HC is particularly neuroprotective.
If the neuroprotective effects of 25-HC are entirely through antagonism of NMDAR function and endogenous, local 24S-HC, we would expect that 25-HC should also reduce direct
NMDA-induced cell death. To test this, NMDA was exogenously applied at either 8 μM or
20 μM to induce mild or severe neuronal injury (Fig 5A). Under these conditions, 25-HC
exhibited no neuroprotection, regardless of the severity of NMDA toxicity (Fig 5A). However,
co-treatment with 24S-HC exacerbated NMDA toxicity, and this exacerbation was significantly alleviated by 25-HC (Fig 5B). These results suggest that 25-HC does not affect basal
NMDAR activity by antagonizing local 24S-HC actions during excitotoxicity.
Our results so far suggest that 25-HC may protect neurons during and after OGD, independent of NMDAR activity. As a final test, we applied a stronger OGD insult by increasing OGD
exposure time from 2.5 h to 3–4 h to help emphasize any NMDAR-independent mechanisms
of OGD-induced death. Under these conditions, cell death was only be partially rescued by
NMDAR blockade with 20 μM MK-801, a non-competitive NMDAR channel blocker. To
ensure that NMDARs were fully blocked under this condition, we co-treated cultures with
1 μM SGE-201. If unblocked NMDARs contribute to the residual death in the presence of
MK-801, we would expect exacerbation of cell loss. In contrast to this expectation, 1 μM SGE201 failed to exacerbate OGD toxicity in the presence of 20 μM MK-801 (Fig 6B; n = 9 cultures,
P > 0.05), suggesting complete inhibition of NMDAR activity. Nevertheless, 20 μM 25-HC
yielded mild but significant neuroprotection in the presence of 20 μM MK-801 (Fig 6A). This
finding strongly supports the hypothesis that 25-HC is mildly neuroprotective against OGDinduced cell death through a mechanism independent of NMDAR inhibition.
To further test the NMDAR-independent neuroprotective effect, we used a model of oxidative damage: H2O2 induced toxicity. In the presence of MK-801 to eliminate contributions of
NMDARs, 25-HC had a similarly mild but consistent neuroprotective effect to that observed
in OGD insult (Fig 6C). Despite these consistent effects in rat cultures, we were surprised to
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Fig 4. 25-HC alone is neuroprotective against OGD-induced cell death, independent of NMDARs. (A)
Survival rates from cultures treated with APV before or after OGD insult were normalized to the survival rate of
cultures treated with OGD alone. APV (50 μM) administered before OGD insult had significantly larger
neuroprotective effects on the survival rate compared to APV administered after OGD insult (n = 7 cultures for
APV-before; n = 15 cultures for APV-after; *P < 0.05). (B) Survival rates from cultures treated with 25-HC
before or after OGD insult were normalized to the survival rate of cultures treated with OGD alone.
Administration of 25-HC (10 μM) before and after OGD insult had indistinguishable rescuing effects on
survival (n = 15 cultures for each group; P > 0.2).
https://doi.org/10.1371/journal.pone.0174416.g004

find that the NMDAR-independent neuroprotective effect did not extend to either WT or
CYP46A1-/- cultures (Fig 6D and 6E). Therefore, the mild NMDAR independent neuroprotective effect of 25-HC appears to be species specific.

Discussion
Our results extend the understanding of a class of NMDAR positive allosteric modulators that
has been hiding in plain sight for decades. 24S-HC is the main cholesterol metabolite in brain
and is responsible for brain cholesterol elimination as new cholesterol is synthesized [4].

Fig 5. 25-HC alone does not protect against NMDA-induced cell death, but it alleviates 24S-HC
exacerbated toxicity. (A) Application of NMDA at 8 μM and 20 μM significantly reduced cell survival, which
was not inhibited when cells were co-treated with 10 μM 25-HC (n = 13 cultures for each group, one-way
repeated measures ANOVA with Bonferroni’s post hoc test, ***P < 0.001). (B) Application of 24S-HC
significantly exacerbated 8 μM NMDA-induced cell death. The exacerbation was inhibited by 10 μM 25-HC
(n = 6 cultures for each group, one-way repeated measures ANOVA with Bonferroni’s post hoc test,
*P < 0.05).
https://doi.org/10.1371/journal.pone.0174416.g005
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Fig 6. 25-HC has a species-dependent, NMDAR-independent protecting effect on OGD-induced cell
death. (A) Survival rate in rat cultures was compared between control, OGD (3 hr), OGD (3 hr) + MK-801
(20 μM), and OGD (3 hr) + MK-801(20 μM)+ 25-HC (20 μM). Cell death induced by more severe OGD (3 hr)
was only partially inhibited by MK-801 application. 25-HC protected against the MK-801 insensitive OGDinduced cell death. (n = 12 cultures for each group, one-way repeated measures ANOVA with Sidak’s post
hoc test, **P < 0.01, ***P < 0.001). As in other experiments with 25-HC, neuroprotection was modest but
reliable across experiments. (B) SGE-201 did not increase cell death, verifying the NMDAR independence
(N = 9 cultures for each group; P > 0.05). (C) H2O2 (100 μM, 1 hour treatment) toxicity was used to test
neuroprotection of 25-HC. 25-HC again yielded mild but reliable protection (N = 10 cultures for each group,
one-way repeated measures ANOVA with Bonferroni’s post hoc test, *P < 0.05). (D) and (E) Neither WT nor
CYP46A1 KO hippocampal neuron cultures from C57Bl/6 mice was sensitive to the mild NMDAR
independent neuroprotective effect of 25-HC (N = 7 cultures for each group; P > 0.05).
https://doi.org/10.1371/journal.pone.0174416.g006

Recent discoveries have demonstrated additional roles for 24S-HC, including acute modulatory effects on NMDARs [3], transcriptional effects through the liver X receptor [20] and perhaps other signaling roles as well [21, 22]. It is also a candidate biomarker for a number of
neurodegenerative diseases [22–26]. The results of the present study support the idea that
24S-HC may contribute to neuronal death in certain circumstances, in addition to serving as a
biomarker of cell death. Our results support the idea that in OGD, 24S-HC’s exacerbation of
damage is mainly through NMDARs. By contrast a less abundant oxysterol, 25-HC, acts as a
neuroprotective agent through both NMDAR-dependent and NMDAR-independent
mechanisms.
Our results revealed that OGD-induced cell death exacerbated by 24S-HC can be prevented
by the NMDAR antagonists APV (Fig 1B) and MK-801 (Fig 6), suggesting that 24S-HC exacerbated injury is NMDAR dependent. This is consistent with previous findings that 24S-HC
specifically potentiates NMDAR function [3]. Other studies, however, also found that 24S-HC
may promote toxicity that is independent of NMDARs. At concentrations above 10 μM,
24S-HC induced cell death in SH-SY5Y human neuroblastoma cells, as well as cultured cortical neurons [7]. 24S-HC can also induce apoptosis in human T-lymphoma Jurkat cells via activation of caspase 8, a mechanism not observed in SH-SY5Y cells [8]. These findings
demonstrate that 24S-HC alone can induce cell death in an NMDAR-independent manner.
Nevertheless, we failed to find consistent effects of 24S-HC when administered alone (Fig 1B),
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and the primary effect of 24S-HC in the present work was an NMDAR dependent exacerbation of OGD-induced neuronal loss. Potential explanations for differences between the above
studies and ours include cell-type differences and higher 24S-HC concentrations in previous
studies (10–50 μM).
Our studies included evaluation of the potential role of endogenous 24S-HC. Endogenous
24S-HC exacerbated OGD-induced cell death (Fig 2). However, because OGD was performed
in 24S-HC-free medium (Fig 2B), we posit that local 24S-HC levels, near sites of release, must
be responsible for the effects of genetic overexpression and underexpression of CYP46A1.
Local 24S-HC must exceed ~50 nM (Fig 3A) [3], the exogenous concentration needed to
potentiate NMDAR function. Another possibility is that 24S-HC, which is difficult to remove
from cell membranes [3], was retained from conditioned medium and contributed to
NMDAR damage during OGD.
Endogenous 24S-HC may be elevated by excitatory synaptic transmission [27–29]. Hippocampal cultures exhibit age-related, activity-dependent cholesterol loss that involves reactive
oxygen species, CYP46A1 mobilization [27, 28], and elevated 24S-HC in culture medium [29].
In contrast, our results revealed no evidence that OGD increases 24S-HC release (Fig 2C).
Nevertheless, we cannot exclude the possibility of local increases in 24S-HC concentration following OGD-induced NMDAR stimulation that were not reflected in bulk medium.
Interestingly, our results revealed neuroprotection by 25-HC against OGD-induced cell
death in rat cultures, both in the presence and absence of exogenous 24S-HC application. It is
unlikely that endogenous 25-HC participated in the observed neuroprotective effects since its
brain concentrations are very low relative to 24S-HC and to neuroprotective concentrations of
25-HC used in our studies [6, 30]. Neuroprotection against exogenous 24S-HC exacerbated
toxicity is NMDAR dependent (Figs 3 and 5B) and is consistent with our previous work demonstrating that 25-HC antagonizes 24S-HC-mediated NMDAR potentiation [9]. However,
25-HC exhibited another, small protective effect in rat tissue, revealed in the absence of
24S-HC and in the absence of NMDAR contributions (Figs 4–6). The lack of detectable effect
of 25-HC on the endogenous 24S-HC actions in OGD and NMDA toxicity (Figs 4B and 5)
could result from the low levels of 24S-HC present, combined with the relatively weak antagonism of 25-HC [9]. Interaction between 25-HC and oxysterol-binding proteins [31] drives cell
survival in non-neuronal, proliferating cell types [32, 33]. Future work can test the relevance of
this mechanism and others to OGD neuroprotection, although the importance of the
NMDAR independent mechanism of 25-HC neuroprotection ultimately may be limited by
species dependence (Fig 6).

Conclusions
Results from this study support the hypothesis that 24S-HC exacerbates NMDAR-dependent
excitotoxicity induced by OGD, an ischemia-like challenge. In addition, 25-HC protects
against OGD-induced cell death, even when administered following the insult. While 25-HC
rescues NMDAR-dependent cell death exacerbated by 24S-HC, 25-HC exhibits species-dependent, NMDAR-independent neuroprotection against OGD-induced cell death. Our findings
suggest that two oxysterols may both contribute to severity of damage and be palliative targets
in ischemic stroke.
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